135 related articles for article (PubMed ID: 30779127)
1. The clinical significance and prognostic value of Xenopus kinesin-like protein 2 expressions in human tumors: A systematic review and meta-analysis.
Yang W; Wan H; Shan R; Wen W; Li J; Luo D; Wan RH
J Cell Physiol; 2019 Sep; 234(9):14991-14998. PubMed ID: 30779127
[TBL] [Abstract][Full Text] [Related]
2. Clinical value of Xenopus kinesin-like protein 2 as a prognostic marker in patients with digestive system cancers: a systematic review and meta-analysis.
Wang G; Wang Q; Li Z; Liu C; He X
Onco Targets Ther; 2018; 11():1229-1243. PubMed ID: 29551902
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and clinical value of Targeting protein for Xenopus kinesin-like protein 2 in patients with gastrointestinal tract cancers: A meta-analysis.
Liu W; Xu J; Zhang C
Medicine (Baltimore); 2018 Nov; 97(46):e13303. PubMed ID: 30431618
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis.
Zhu S; Shuai P; Yang C; Zhang Y; Zhong S; Liu X; Chen K; Ran Q; Yang H; Zhou Y
Oncotarget; 2017 Dec; 8(68):113174-113184. PubMed ID: 29348896
[TBL] [Abstract][Full Text] [Related]
5. The Clinicopathological and Prognostic Significance of IDO1 Expression in Human Solid Tumors: Evidence from a Systematic Review and Meta-Analysis.
Yu CP; Fu SF; Chen X; Ye J; Ye Y; Kong LD; Zhu Z
Cell Physiol Biochem; 2018; 49(1):134-143. PubMed ID: 30134237
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
[No Abstract] [Full Text] [Related]
7. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
8. TPX2 expression is associated with poor survival in gastric cancer.
Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
10. TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.
Liu Q; Tu K; Zhang H; Zheng X; Yao Y; Liu Q
Hepatol Res; 2015 Aug; 45(8):906-18. PubMed ID: 25263743
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of SNHG6 in human cancers: a meta-analysis.
Zhao S; Zhu H; Jiao R; Wu X; Ji G; Zhang X
BMC Cancer; 2020 Jan; 20(1):77. PubMed ID: 32000704
[TBL] [Abstract][Full Text] [Related]
13. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
14. Expression of microtubule-associated protein TPX2 in human gastric carcinoma and its prognostic significance.
Shao C; Duan C; Wang J; Luan S; Gao Y; Jin D; Wang D; Li Y; Xu L
Cancer Cell Int; 2016; 16():79. PubMed ID: 27777511
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
Hu L; Huang M; Yuan Q; Kong F
Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of targeting protein for Xklp2 in solid tumors: A PRISMA-compliant systematic review and meta-analysis.
Wang S; Chen Y; Chai Y
Medicine (Baltimore); 2018 Oct; 97(43):e13018. PubMed ID: 30412141
[TBL] [Abstract][Full Text] [Related]
17. TPX2 as a Novel Prognostic Indicator and Promising Therapeutic Target in Triple-negative Breast Cancer.
Jiang Y; Liu Y; Tan X; Yu S; Luo J
Clin Breast Cancer; 2019 Dec; 19(6):450-455. PubMed ID: 31494045
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis.
Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L
Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of TPX2 is associated with progression and prognosis of prostate cancer.
Zou J; Huang RY; Jiang FN; Chen DX; Wang C; Han ZD; Liang YX; Zhong WD
Oncol Lett; 2018 Sep; 16(3):2823-2832. PubMed ID: 30127868
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of high FOXO3a expression in patients with solid tumors: A meta-analysis and systematic review.
Wang C; Tu X; Jiang Y; Jiao P; Deng X; Xie Y; Zhang L
Int J Biol Markers; 2022 Jun; 37(2):210-217. PubMed ID: 35484793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
